DEA schedule
Is phendimetrazine a controlled substance?
Federal schedule for phendimetrazine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Phendimetrazine is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Phendimetrazine (Schedule III).
Run it in Rivvi
Which 2027 plans near you dropped or restricted phendimetrazine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 20 prescription listings from 12 labelers, all Schedule III |
| DEA controlled substances list | Phendimetrazine: Schedule III |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Phendimetrazine | 1615 | III | No | Plegine; Prelu-2; Bontril; Melfiat; Statobex | Listed by name |
Phendimetrazine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 72989-409 | PHENDIMETRAZINE TARTRATE | capsule, extended release | 105 mg/1 | Acertis Pharmaceuticals, LLC | CIII |
| 10702-045 | Phendimetrazine Tartrate | tablet | 35 mg/1 | KVK-TECH, INC | CIII |
| 10702-077 | Phendimetrazine Tartrate | tablet | 35 mg/1 | KVK-TECH, INC | CIII |
| 10702-078 | Phendimetrazine Tartrate | tablet | 35 mg/1 | KVK-TECH, INC | CIII |
| 17224-800 | Phendimetrazine Tartrate | tablet | 35 mg/1 | Calvin Scott & Co., Inc. | CIII |
| 43063-510 | Phendimetrazine Tartrate | tablet | 35 mg/1 | PD-Rx Pharmaceuticals, Inc. | CIII |
| 50090-0715 | Phendimetrazine Tartrate | tablet | 35 mg/1 | A-S Medication Solutions | CIII |
| 50090-2235 | Phendimetrazine Tartrate | tablet | 35 mg/1 | A-S Medication Solutions | CIII |
| 50090-6552 | Phendimetrazine Tartrate | tablet | 35 mg/1 | A-S Medication Solutions | CIII |
| 63629-2489 | PHENDIMETRAZINE TARTRATE | tablet | 35 mg/1 | Bryant Ranch Prepack | CIII |
| 64850-440 | PHENDIMETRAZINE TARTRATE | tablet | 35 mg/1 | Elite Laboratories, Inc | CIII |
| 66267-394 | Phendimetrazine Tartrate | tablet | 35 mg/1 | NuCare Pharmaceuticals, Inc, | CIII |
| 68071-3509 | PHENDIMETRAZINE TARTRATE | tablet | 35 mg/1 | NuCare Pharmaceuticals,Inc. | CIII |
| 68071-3839 | Phendimetrazine Tartrate | tablet | 35 mg/1 | NuCare Pharmaceuticals, Inc. | CIII |
| 68788-7236 | Phendimetrazine Tartrate | tablet | 35 mg/1 | Preferred Pharmaceuticals Inc. | CIII |
| 69543-410 | PHENDIMETRAZINE TARTRATE | tablet | 35 mg/1 | Virtus Pharmaceuticals, LLC | CIII |
| 71335-0074 | Phendimetrazine Tartrate | tablet | 35 mg/1 | Bryant Ranch Prepack | CIII |
| 71335-0324 | Phendimetrazine Tartrate | tablet | 35 mg/1 | Bryant Ranch Prepack | CIII |
| 71335-1840 | PHENDIMETRAZINE TARTRATE | tablet | 35 mg/1 | Bryant Ranch Prepack | CIII |
| 72162-2044 | PHENDIMETRAZINE TARTRATE | tablet | 35 mg/1 | Bryant Ranch Prepack | CIII |
Questions
Is phendimetrazine a controlled substance?
Yes. Phendimetrazine is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Phendimetrazine (Schedule III).
Is phendimetrazine a narcotic?
No. The DEA list does not mark phendimetrazine as a narcotic (NARC = N) and places it in Schedule III. Its FDA established pharmacologic class is Sympathomimetic Amine Anorectic.
What schedule is phendimetrazine?
Phendimetrazine is Schedule III in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.